Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

SWX/LLY stock hub

SWX/LLY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SWX/LLYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

657.6B

SIX Swiss Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SWX/LLY

In the news

Latest news · SWX/LLY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.4

P25 15.9P50 20.7P75 33.1

Trailing P/E32.4

P25 19.6P50 21.4P75 37.6

ROE107.5

P25 -6.1P50 7.9P75 17

ROIC41.9

P25 -4.4P50 6.6P75 15.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SWX/LLY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

USD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CH
Employees	50,000
Employees Change	4,000%
Employees Change Percent	9.3
Enterprise value	CHF 686.9B
Exchange	SIX Swiss Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US5324571083
Last refreshed	2026-05-10
Market cap	CHF 657.6B
Price	CHF 760
Price currency	CHF
Rev Per Employee	1,159,047.36x
Sector	Healthcare
Sic	2834
Symbol	swx/LLY
Website	https://www.lilly.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.08%
EV Earnings	33.88x
EV/EBIT	25.85x
EV/EBITDA	24.25x
EV/FCF	72.43x
EV/Sales	12.23x
FCF yield	1.44%
Forward P/E	25.41x
P/B ratio	26.28x
P/E ratio	32.43x
P/S ratio	11.35x
PE Ratio10 Y	52.61x
PE Ratio3 Y	73.78x
PE Ratio5 Y	62.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	47.3%
EBITDA Margin	50.13%
FCF margin	16.36%
Gross margin	82.83%
Gross Profit	CHF 48B
Gross Profit Growth	49.48%
Gross Profit Growth Q	54.44%
Gross Profit Growth3 Y	40.65%
Gross Profit Growth5 Y	25.35%
Net Income	CHF 20.3B
Net Income Growth	127.6%
Net Income Growth Q	168.07%
Net Income Growth Quarters	10%
Net Income Growth Years	2%
Net Income Growth3 Y	64.42%
Net Income Growth5 Y	32.92%
Pretax Margin	43.08%
Profit Margin	34.99%
Profit Per Employee	CHF 405,504
Profitable Years	8
ROA	20.74
Roa5y	13.51
ROCE	42.75
ROE	107.5
Roe5y	74.21
ROIC	41.92
Roic5y	35.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	28.67%
Cagr15y	26.18%
Cagr1y	16.03%
Cagr20y	16.53%
Cagr3y	26.5%
Cagr5y	36.15%
Div CAGR10	9.86%
Div CAGR3	8.83%
Div CAGR5	12.01%
EPS Growth	129.1
EPS Growth Q	169.9
EPS Growth Quarters	10
EPS Growth Years	2
EPS Growth3 Y	64.8
EPS Growth5 Y	33.34
FCF Growth	216.44%
FCF Growth Q	1,827.56%
FCF Growth3 Y	36.63%
FCF Growth5 Y	13.11%
OCF Growth	119.79%
OCF Growth Q	220.11%
OCF Growth10 Y	21.88%
OCF Growth3 Y	44.46%
OCF Growth5 Y	21.25%
Revenue Growth	47.44x
Revenue Growth Q	55.54x
Revenue Growth Quarters	12x
Revenue Growth Years	7x
Revenue Growth3 Y	37.67x
Revenue Growth5 Y	23.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.7
Assets	CHF 93.5B
Cash	CHF 4.2B
Current Assets	CHF 42.6B
Current Liabilities	CHF 28.5B
Debt	CHF 34.8B
Debt EBITDA	CHF 1.19
Debt Equity	CHF 1.39
Debt FCF	CHF 3.67
Equity	CHF 25B
Interest Coverage	388.3
Liabilities	CHF 68.5B
Long Term Assets	CHF 50.9B
Long Term Liabilities	CHF 40B
Net Cash	CHF -30.2B
Net Cash By Market Cap	CHF -4.59
Net Debt EBITDA	CHF 1.04
Net Debt Equity	CHF 1.21
Net Debt FCF	CHF 3.18
Tangible Book Value	CHF 14.2B
Tangible Book Value Per Share	CHF 15.88
WACC	6.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.5
Inventory Turnover	1.04
Net Working Capital	CHF 13.6B
Quick ratio	0.72
Working Capital	CHF 14.6B
Working Capital Turnover	CHF 3.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.57%
Dividend Growth	3.63%
Dividend Growth Years	11%
Dividend per share	CHF 4.99
Dividend Years	35
Dividend Yield	0.66%
Ex Div Date	2026-02-13
Last Dividend	CHF 1.33
Payout Frequency	Quarterly
Payout Ratio	22.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,143.76%
1Y total return	16.02%
200-day SMA	727.6
3Y total return	102.47%
50-day SMA	742.9
50-day SMA vs 200-day SMA	50over200
5Y total return	367.66%
All Time High	900
All Time High Change	-15.56%
All Time High Date	2026-02-09
All Time Low	5.68
All Time Low Change	13,273.22%
All Time Low Date	1993-04-27
ATR	11.57
Beta	0.48
Ch YTD	-10.59
High52	900
High52 Date	2026-02-09
High52ch	-15.56%
Low52	537.2
Low52 Date	2025-05-20
Low52ch	41.48%
Ma50ch	2.3%
Price vs 200-day SMA	4.46%
RSI	58.78
RSI Monthly	55.87
RSI Weekly	50.79
Sharpe ratio	0.41x
Sortino ratio	0.83
Total Return	1.23%
Tr YTD	-10.44
Tr15y	3,174.16%
Tr1m	2.7%
Tr1w	0.66%
Tr3m	-14.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 27.4B
Operating Income Growth	74.29
Operating Income Growth Q	84.42
Operating Income Growth3 Y	64.3
Operating Income Growth5 Y	36.9
Operating margin	47.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	889,347,313%
Net Borrowing	3,468,327,120
Shares Insiders	0.17%
Shares Institutions	90.01%
Shares Qo Q	-0.23%
Shares Yo Y	-0.57%
Short Ratio	2.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 9B
Average Volume	5.85x
Bv Per Share	28.01
CAPEX	CHF -6.9B
Ch10y	951.2
Ch15y	2,189.2
Ch1m	2.7
Ch1w	0.66
Ch1y	15.15
Ch20y	1,093.1
Ch3m	-14.61
Ch3y	97.92
Ch5y	344.4
Change	0%
Close	760
Depreciation Amortization	1,587,319,065
Earnings Date	2026-04-30
EBIT	CHF 27.4B
EBITDA	CHF 29B
EPS	CHF 22.58
F Score	6
FCF	CHF 9.5B
FCF EV Yield	1.38x
Financing CF	-5,665,373,560
Fiscal Year End	December
Founded	1,876
Goodwill	4,762,734,150
Graham Number	123.48091
Graham Upside	-83.75
Income Tax	CHF 4.7B
Investing CF	-9,252,454,200
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	CHF 586
Lynch Upside	-22.92
Ma150	771
Ma150ch	-1.43%
Ma20	724
Ma20ch	4.97%
Net CF	1,755,840,680
P FCF Ratio	69.34
P OCF Ratio	40.03
Payment Date	2026-03-10
Ppne	20,620,385,700
Price Date	2026-05-08
Price EBITDA	CHF 22.64
Ptbv Ratio	46.33
Relative Volume	0.17x
Revenue	57,952,367,880x
SBC By Revenue	0.88x
Share Based Comp	507,741,960
Tax By Revenue	8.09x
Tax Rate	18.79%
Tr20y	2,032.69%
Tr6m	0.32%
Z Score	7.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SWX/LLY dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$4.99 annual per share

Payout ratio

+22.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+12.0%

11 consecutive years of growth

Total shareholder yield

+1.2%

Next ex-dividend date: 2026-02-13

Performance

SWX/LLY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SWX/LLY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.0%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SWX/LLY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.8

Neutral momentum band

Price vs 200-day MA

+4.5%

50/200-day relationship not available

Beta (5Y)

0.48

Less volatile than the market

Sharpe ratio

0.41

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SWX/LLY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current swx/LLY stock rating?

swx/LLY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full swx/LLY analysis?

The full report lives at /stocks/swx/LLY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for swx/LLY?

The latest report frames swx/LLY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the swx/LLY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.